| Literature DB >> 32722243 |
Yung Hyun Jeon1, Kyun Hee Cho2, Shin Jun Park3.
Abstract
After a stroke, forward head posture occurs, resulting in swallowing dysfunction. Neuromuscular electrical stimulation (NMES) combined with upper cervical spine mobilization has demonstrated enhanced recovery of the swallowing function in stroke patients. This study investigated the therapeutic effects of NMES in conjunction with upper cervical mobilization in stroke patients with dysphagia. Thirty-four stroke patients were recruited (in a randomized controlled clinical trial) and divided into an experimental group (n = 17; NMES plus upper cervical spine mobilization) and a control group (n = 17; NMES plus sham mobilization). Forward head posture was measured by craniocervical flexion test (CCFT) and craniovertebral angle (CVA). Swallowing function was measured by variations in video fluoroscopic dysphagia scale (VDS) and penetration-aspiration scale (PAS) scores using the video fluoroscopic swallowing study (VFSS). All measurements were done at baseline and after four weeks of NMES plus mobilization. A significant increase was observed in CCFT, CVA, VDS (total VDS score, oral stage score, pharyngeal stage score), and PAS score in all variations in the experimental group. The CCFT, CVA, pharyngeal stage score, total VDS, and PAS score were significantly higher in the experimental group when compared to the control group. NMES plus upper cervical spine mobilization can be regarded as a promising method to improve swallowing function and forward head posture changes in stroke patients with dysphagia.Entities:
Keywords: CCFT; NMES; dysphagia; joint mobilization; swallowing dysfunction
Year: 2020 PMID: 32722243 PMCID: PMC7464773 DOI: 10.3390/brainsci10080478
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Subject characteristics.
| Classification | Experimental Group ( | Control Group ( |
|
|
|---|---|---|---|---|
| Gender (male/female) | 11/6 | 11/6 | 0.100 | |
| Paretic side (left/right) | 6/11 | 7/10 | 0.100 | |
| Hemorrhages/Infarction | 14/3 | 12/5 | 0.688 | |
| Disease duration (months) a | 12.00 ± 2.09 | 11.82 ± 2.43 | 0.723 | |
| Age (years) a | 63.12 ± 13.50 | 64.47 ± 8.43 | 0.728 | |
| Weight (kg) a | 69.11 ± 11.95 | 65.55 ± 12.66 | 0.406 | |
| Height (cm) a | 165.65 ± 9.45 | 164.58 ± 9.16 | 0.739 | |
| K-MMSE d (point) a | 24.53 ± 2.62 | 24.24 ± 2.91 | 0.759 | |
| K-NIHSS e (point) a | 10.41 ± 3.06 | 10.76 ± 3.75 | 0.766 |
a Values are denoted as mean ± SD. b Chi-square test among two intervention groups. c Independent t-test among two intervention groups. d K-MMSE: Korean mini-mental state examination. e K-NIHSS: Korean national institute of health stroke scale.
Changes in CCFT and CVA outcome of two intervention groups.
| Measure/Group | Baseline Test a | Post-Test a | Within-Subject | Between-Subject Change b |
|---|---|---|---|---|
| CCFT (performance index) | ||||
| Experimental group | 9.06 ± 4.19 | 17.53 ± 5.72 | 8.47 (5.17,11.77) * | 4.94(0.81,9.08) ** |
| Control group | 8.94 ± 3.94 | 12.47 ± 4.45 | 3.53 (0.77,6.29) * | |
| CVA (degree) | ||||
| Experimental group | 42.64 ± 4.85 | 49.49 ± 2.12 | 6.86 (4.85,8.87) * | 2.86(0.36,5.37) ** |
| Control group | 42.15 ± 3.98 | 45.26 ± 3.54 | 3.11 (1.38,4.84) * | |
a Values are means ± SD. b Values are 95% confidence interval. * Within-subject factors: significant increase from the baseline test. ** Between-subject factors (Interaction): significant increase from the control group. Experimental group: NMES (Neuromuscular electrical stimulation) plus upper cervical spine mobilization. Control group: NMES plus sham mobilization. CCFT: craniocervical flexion test. CVA: craniovertebral angle.
Changes in swallowing function outcome of two intervention groups.
| Measure/Group | Baseline Test a | Post-Test a | Within-Subject | Between-Subject Change b |
|---|---|---|---|---|
| VDS (point) | ||||
| Oral phase | ||||
| Experimental group | 15.18 ± 4.73 | 8.97 ± 4.85 | −6.21 (−8.43,−3.98) * | −1.85 (−4.73,1.02) |
| Control group | 14.65 ± 5.16 | 10.29 ± 4.77 | −4.35 (−6.35,−2.35) * | |
| Pharyngeal phase | ||||
| Experimental group | 43.77 ± 7.24 | 15.32 ± 7.89 | −28.44 (−33.96,−22.93) * | −14.94 (−22.66,−7.23) ** |
| Control group | 42.91 ± 7.96 | 29.41 ± 10.62 | −13.50 (−19.33,−7.67) * | |
| Total score | ||||
| Experimental group | 58.94 ± 11.22 | 24.29 ± 7.75 | −34.65 (−39.44, −29.86) * | −16.91 (−24.12,−9.71) ** |
| Control group | 57.32 ± 11.14 | 39.71 ± 13.01 | −17.62 (−23.45,−11.79) * | |
| PAS (point) | ||||
| Experimental group | 4.94 ± 1.64 | 1.88 ± 0.78 | −3.06 (−3.82,−2.30) * | −2.06 (−2.91,−1.21) ** |
| Control group | 4.76 ± 1.44 | 3.76 ± 1.20 | −1.00 (−1.45,−0.56) * | |
a Values are means ± SD. b Values are 95% confidence interval. * Within-subject factors: significant increase from the baseline test. ** Between-subject factors (Interaction): significant increase from the control group. Experimental group: NMES plus upper cervical spine mobilization. Control group: NMES plus sham mobilization. VDS: video fluoroscopic dysphagia scale. PAS: penetration–aspiration scale.